Our Ambitious Quest to Cure Cancer!
A Unique Partnership to Double the Impact!
We have seen incredible progress since we first began our fundraising campaigns four years ago. From the hypotheses stage of cancer cell migration to visualizing the birth of therapeutic resistance from the Keystone Cancer Cells (KCCs), Dr. Ken Pienta, his team at The Brady Urological Institute, Johns Hopkins Medicine and our #StevensStrong team have come so far. Thank you for joining us in our fight against metastatic cancer!
The discovery of the KCCs has energized the scientific community, and the Prostate Cancer Foundation (PCF) wants to help! In 2021, PCF coordinated a $1M matching challenge towards the #StevensStrong campaign to accelerate Dr. Pienta’s efforts to develop novel therapies to beat resistance and metastasis.
Mary and I, and our dear friends, Jim and Judy Deitch, kicked-off the matching campaign with a total commitment of $400,000 over 3 years. Thank you for helping us to beat our $1M goal! Every dollar we raised was matched 1:1. Although the match is now fulfilled, Dr. Pienta’s research team is still accepting contributions to help support their ongoing investigations of the KCCs.
If you would like to make a gift, please click on the Donate link below to be directed to The Brady Urological Institute’s giving page. 100% of your donation will support Dr. Pienta and his research team! When you visit the link, select Other in the designation drop-down and type in “Dr. Ken Pienta and #StevensStrong” in the Please Describe field. If you have questions, please contact Jillian Beam from The Brady’s Development Team at jbeam5@jhmi.edu or (410) 955-8434.
In the words of Dr. Pienta…
CHARGE!
The confocal microscope purchased by our #StevensStrong network in 2018. This microscope enabled Dr. Pienta and his team to discover the KCCs.
Drs. Ken Pienta and Sarah Amend with the Incucyte cell machine purchased by #StevensStrong in 2020 to characterize the KCCs and test the efficacy of selected therapeutics.
Drs. Pienta and Amend with the WOLF cell sorter, purchased by the #StevensStrong network in 2021, which will be used to isolate the KCCs.
Thank you for being our partners in discovery! - Dave & Mary Stevens
To learn To learn more about Dr. Pienta and Keystone Cancer Cells, please visit www.kennethjpienta.com
Bridging the Valley of Death
Dr. Pienta’s team is gearing up to develop, test and screen the therapeutics that could cure all metastatic cancers. The immediate next step is to identify the cellular targets to destroy the KCCs. Unfortunately, traditional grants do not fund target identification and neither do commercial entities. That is why it is called the “Valley of Death” in drug development. Once a target is identified, biotech and Pharma will license the discovery and support the clinical development! But we have to find the targets first!
We ask you to join us again to help Dr. Pienta’s team cross the bridge to bring an end to metastatic disease, once and for ALL. 100% of your donation will benefit the research!
Our #StevensStrong Donors
